Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01999764 · ClinicalTrials.gov registry record · Phase 2
Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation
A Phase 2 study, sponsored by QLT.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT01999764 is a Phase 2 study that has completed, run by QLT. The registered enrollment target is 43 participants.
The verdict
NCT01999764, a Phase 2 study, has completed, sponsored by QLT.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
This is a Phase IIa proof-of-concept study to evaluate the effects of oral QLT091001 on adults with impaired dark adaptation.
Interventions
- OTHER Placebo
- DRUG QLT091001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01999764
The ClinicalTrials.gov registry entry for NCT01999764 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is QLT, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01999764 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01999764 about?
NCT01999764 is a clinical study titled "Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation". This is a Phase IIa proof-of-concept study to evaluate the effects of oral QLT091001 on adults with impaired dark adaptation.
What is the current status of trial NCT01999764?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2013-11. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01999764?
The interventions under investigation include: Placebo (OTHER), QLT091001 (DRUG).
Who is sponsoring clinical trial NCT01999764?
This trial is sponsored by QLT, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.